Insights into the choice between intravenous infusion and subcutaneous injection: physician and patient characteristics driving treatment in SLE.

ABSTRACT:

Introduction/objectives

Multiple modes of administration are available for systemic lupus erythematosus (SLE) treatments. This study examined patient and physician characteristics associated with the choice of weekly subcutaneous (SC) injection or monthly intravenous (IV) infusion for an unspecified SLE treatment.

Methods

This was a cross-sectional, US web-based survey using a direct elicitation, stated-preference methodology (HO-16-16706). Two hundred patients and 200 physicians were asked to choose between IV or SC administration in a hypothetical scenario. Pairwise and multivariate analyses estimated the odds ratio (OR) for the likelihood of choosing SC over IV for respondent characteristics.

Results

Among patients, taking non-steroidal anti-inflammatory drugs incr

SUBMITTER: Bell CF 

PROVIDER: S-EPMC7817604 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature